Gateway Investment Advisers LLC trimmed its position in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 39.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,725 shares of the health services provider's stock after selling 18,560 shares during the quarter. Gateway Investment Advisers LLC's holdings in Universal Health Services were worth $5,154,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in the company. Financial Management Professionals Inc. purchased a new position in Universal Health Services during the third quarter worth about $32,000. True Wealth Design LLC purchased a new position in shares of Universal Health Services in the 3rd quarter worth approximately $39,000. Huntington National Bank boosted its stake in shares of Universal Health Services by 414.3% in the 3rd quarter. Huntington National Bank now owns 180 shares of the health services provider's stock worth $41,000 after buying an additional 145 shares during the last quarter. Benjamin F. Edwards & Company Inc. increased its position in shares of Universal Health Services by 41.8% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 251 shares of the health services provider's stock valued at $46,000 after acquiring an additional 74 shares during the last quarter. Finally, Sentry Investment Management LLC bought a new stake in Universal Health Services during the third quarter worth $64,000. Institutional investors own 86.05% of the company's stock.
Analyst Ratings Changes
UHS has been the subject of a number of recent analyst reports. KeyCorp assumed coverage on Universal Health Services in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. TD Cowen decreased their price target on shares of Universal Health Services from $275.00 to $251.00 and set a "buy" rating for the company in a research note on Tuesday, November 26th. Barclays upped their price objective on Universal Health Services from $256.00 to $271.00 and gave the company an "overweight" rating in a research note on Friday, October 25th. Bank of America started coverage on Universal Health Services in a research report on Wednesday, November 6th. They issued a "neutral" rating and a $223.00 target price for the company. Finally, The Goldman Sachs Group cut Universal Health Services from a "buy" rating to a "neutral" rating and dropped their price target for the company from $228.00 to $198.00 in a research report on Monday, December 16th. Seven research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Universal Health Services currently has an average rating of "Moderate Buy" and an average price target of $226.14.
Check Out Our Latest Stock Analysis on Universal Health Services
Insider Buying and Selling at Universal Health Services
In related news, Director Maria Ruderman Singer sold 1,614 shares of the business's stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $191.15, for a total value of $308,516.10. Following the completion of the sale, the director now owns 5,879 shares in the company, valued at $1,123,770.85. The trade was a 21.54 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 16.10% of the stock is currently owned by company insiders.
Universal Health Services Price Performance
NYSE:UHS traded up $0.80 during mid-day trading on Friday, hitting $184.86. 378,391 shares of the stock traded hands, compared to its average volume of 510,642. Universal Health Services, Inc. has a 12-month low of $150.11 and a 12-month high of $243.25. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69. The company has a market cap of $12.19 billion, a PE ratio of 12.29, a price-to-earnings-growth ratio of 0.53 and a beta of 1.30. The business's 50-day moving average price is $190.31 and its 200 day moving average price is $207.39.
Universal Health Services (NYSE:UHS - Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The health services provider reported $3.71 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($0.04). The firm had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.90 billion. Universal Health Services had a return on equity of 15.75% and a net margin of 6.66%. The company's revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.55 EPS. On average, analysts expect that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.
Universal Health Services Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Tuesday, December 3rd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Tuesday, December 3rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.43%. Universal Health Services's dividend payout ratio (DPR) is presently 5.32%.
About Universal Health Services
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
See Also
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.